Hinge Health, Inc.
HNGE
$54.06
-$1.16-2.10%
NYSE
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 646.34M | 587.86M | 534.39M | 480.79M | 431.52M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 646.34M | 587.86M | 534.39M | 480.79M | 431.52M |
| Cost of Revenue | 122.94M | 118.56M | 113.17M | 106.58M | 89.35M |
| Gross Profit | 523.41M | 469.30M | 421.22M | 374.21M | 342.18M |
| SG&A Expenses | 673.99M | 646.46M | 615.25M | 574.19M | 234.97M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 2.59M | 1.08M | 933.00K | 893.00K | -- |
| Total Operating Expenses | 1.17B | 1.13B | 1.09B | 1.03B | 418.89M |
| Operating Income | -527.44M | -546.37M | -552.72M | -550.49M | 12.63M |
| Income Before Tax | -613.63M | -631.44M | -637.49M | -634.40M | 33.19M |
| Income Tax Expenses | 814.00K | 998.00K | -75.00K | 828.00K | 1.52M |
| Earnings from Continuing Operations | -614.45 | -632.44 | -637.41 | -635.23 | 31.67 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -614.45M | -632.44M | -637.41M | -635.23M | 31.67M |
| EBIT | -527.44M | -546.37M | -552.72M | -550.49M | 12.63M |
| EBITDA | -525.34M | -544.24M | -550.54M | -548.26M | 14.87M |
| EPS Basic | -12.29 | -4.81 | -3.23 | -3.21 | 8.94 |
| Normalized Basic EPS | -7.67 | -7.21 | -6.27 | -6.20 | 1.42 |
| EPS Diluted | -12.34 | -11.44 | -9.84 | -9.81 | 2.34 |
| Normalized Diluted EPS | -7.70 | -7.85 | -6.89 | -6.82 | 0.79 |
| Average Basic Shares Outstanding | 280.93M | 217.64M | 151.82M | 86.58M | 56.18M |
| Average Diluted Shares Outstanding | 289.72M | 300.07M | 229.23M | 166.96M | 136.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |